CClinicalTrials.gg
CompletedNCT01276366APIPUpdated Jan 17, 2019

Amphia Premature Infant Pain Study

An interventional study of breast feeding and supplemental breast milk in Premature Infant, Breast Feeding, Exclusive and Puncture Skin, sponsored by Amphia Hospital. Completed at 1 site in Netherlands. Open to participants aged 1 Day to 2 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-17.

Sponsored by Amphia Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
1 Day to 2 Months
Sex
All
01

Study summary

Last thirty years, many research was performed concerning pain in the newborn. These investigations showed us the negative effects of pain in the neonatal period. Our research concerns the choice of analgesics for the premature newborn during a heel lance. Newborns with a gestational age of 32-37 weeks are randomly assigned over three groups. They can receive breastfeeding, during the heel lance, a bottle with supplemental breast milk or sucrose.

The primary objective of the Amphia Premature Infant Pain study, is to investigate whether there is a difference in PIPP-scores in premature newborns who undergo a heel lance, receiving breast milk or sucrose. Our hypothesis is that the PIPP-score will be lower in newborns receiving breast milk compared to sucrose. And the investigators presume that breast feeding has the same analgesic effect as giving supplemental breast milk.

02

Conditions studied

  • Premature Infant
  • Breast Feeding, Exclusive
  • Puncture Skin

Browse trials for

Keywords

  • Heel lance
  • Premature
  • Breast milk
03

Who can participate

Ages eligible
1 Day to 2 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • born at a gestational age between 32+0 and 36+6 weeks,
  • being nourished with breast milk
  • the necessity for a clinical blood sample.

Exclusion criteria

Exclusion Criteria:

  • perinatal asphyxia,
  • birth trauma,
  • condition of cardio-respiratory instability,
  • condition of serious nutritional problems with clinical evidence of gastro oesophageal reflux disease,
  • drug abuse of the mother
  • and application of sedative medication to mother or child.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • Active comparator
    sucrose

    In the third group, newborns receive sucrose 1ml 24% two minutes before procedure, followed by non-nutritive sucking. During the procedure the newborn lies in his cot.

    Other: sucrose

  • Active comparator
    supplemental breast milk

    In group two, the newborns receive supplemental breast milk, lying in the arms of a nurse during the heel lance.

    Other: supplemental breast milk

  • Active comparator
    Breast feeding

    Newborns who are assigned to group one, receive breastfeeding during the blood sample and thereby have skin-skin contact between mother and child.

    Other: breast feeding

Interventions

  • Otherbreast feeding

    Newborns who are assigned to group one, receive breastfeeding during the blood sample and thereby have skin-skin contact between mother and child.

  • Othersupplemental breast milk

    In group two, the newborns receive supplemental breast milk, lying in the arms of a nurse during the heel lance.

  • Othersucrose

    In the third group, newborns receive sucrose 1ml 24% two minutes before procedure, followed by non-nutritive sucking. During the procedure the newborn lies in his cot.

05

What researchers measure

Primary outcomes

  1. Pain scores assessed by the PIPP score

    The primary outcome in this trial is the PIPP-score.The PIPP-score is a multidimensional pain assessment measure developed in 1995 . The PIPP-score is validated for procedural and post-operative pain in premature and term newborns.

    Time frame: The PIPP score will be assessed during a heellance. This heellance will be performed after one day of life and before two months.

Secondary outcomes

  1. Pain score assessed by the COMFORTneo score

    The COMFORTneo is a secondary outcome.The COMFORTneo is a pain assessment measure modified from the COMFORT behaviour scale. In 2009 the COMFORTneo is validated for prolonged pain. The COMFORTneo is not validated for procedural pain yet .

    Time frame: The COMFORTneo score will be assessed during a heellance. This heellance will be performed after one day of life and before two months.

  2. partial correlation between the two pain assessment tools.

    A secondary outcome is the partial correlation between the PIPP-score and the COMFORTneo score for a heellance in babies born with a postconceptional age between 32 and 37 weeks. When all films are observed, the COMFORTneo scores and PIPP scores are evaluated. We measure a partial correlation coefficient between these scores, to compare these two scores.

    Time frame: up to 2 years

  3. intra-class correlation coefficient

    This secondary outcome measure gives us information about the uniformity of the assessment of the films between the three investigators.

    Time frame: up to 2 years

06

Study locations

1 site
  • Amphia Hospital
    Breda, Noord Brabant 4819 VE, Netherlands
07

References and documents

Publications

  • Simonse E, Mulder PG, van Beek RH. Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics. 2012 Apr;129(4):657-63. doi: 10.1542/peds.2011-2173. Epub 2012 Mar 5. PubMed 22392168 ↗
08

Registry details

Key details

Study ID
NCT01276366
Lead sponsor
Amphia Hospital
Responsible party
R.H.T. van Beek (dr. R.H.T. van Beek, Amphia Hospital, pediatric department, Amphia Hospital) — Principal investigator
First posted
Jan 13, 2011
Start date
Jan 1, 2010
Primary completion
Aug 1, 2011
Completion
Apr 1, 2012
Last update
Jan 17, 2019

Study contacts

RHT v Beek, phd
principal investigator · Amphia Hospital Breda

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion